Bicocca Open Archive

Logo unimib boa
CIACCIO, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.841
EU - Europa 2.965
AS - Asia 2.541
SA - Sud America 454
AF - Africa 70
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 8
Totale 11.891
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.698
SG - Singapore 1.030
IT - Italia 675
CN - Cina 661
DE - Germania 490
RU - Federazione Russa 446
SE - Svezia 361
BR - Brasile 359
HK - Hong Kong 356
IE - Irlanda 268
UA - Ucraina 182
VN - Vietnam 174
GB - Regno Unito 162
CA - Canada 109
IN - India 96
FI - Finlandia 65
AT - Austria 61
DK - Danimarca 57
FR - Francia 55
AR - Argentina 34
BD - Bangladesh 32
TR - Turchia 32
NL - Olanda 29
PL - Polonia 29
MX - Messico 26
BE - Belgio 25
ZA - Sudafrica 25
KR - Corea 24
JP - Giappone 21
ES - Italia 19
EC - Ecuador 18
ID - Indonesia 14
IQ - Iraq 14
CO - Colombia 13
VE - Venezuela 11
ET - Etiopia 10
EU - Europa 10
IR - Iran 10
DZ - Algeria 9
SA - Arabia Saudita 9
TW - Taiwan 8
CZ - Repubblica Ceca 7
JO - Giordania 7
MA - Marocco 7
MY - Malesia 6
UZ - Uzbekistan 6
AU - Australia 5
BG - Bulgaria 5
CL - Cile 5
EG - Egitto 5
OM - Oman 5
PK - Pakistan 5
GA - Gabon 4
HU - Ungheria 4
KE - Kenya 4
LT - Lituania 4
MM - Myanmar 4
PE - Perù 4
PH - Filippine 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
CH - Svizzera 3
IL - Israele 3
JM - Giamaica 3
MD - Moldavia 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
TH - Thailandia 3
TN - Tunisia 3
AZ - Azerbaigian 2
BH - Bahrain 2
BO - Bolivia 2
KW - Kuwait 2
NP - Nepal 2
PT - Portogallo 2
RO - Romania 2
RS - Serbia 2
SR - Suriname 2
UY - Uruguay 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BB - Barbados 1
BY - Bielorussia 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
KZ - Kazakistan 1
LB - Libano 1
LI - Liechtenstein 1
ME - Montenegro 1
ML - Mali 1
MN - Mongolia 1
QA - Qatar 1
SC - Seychelles 1
SN - Senegal 1
TJ - Tagikistan 1
Totale 11.890
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.025
Singapore 628
Ashburn 500
Woodbridge 448
Hong Kong 356
Fairfield 350
Chandler 311
Houston 310
Frankfurt am Main 283
Dublin 260
Wilmington 219
New York 179
Jacksonville 178
Milan 170
Dearborn 154
Seattle 130
Cambridge 127
Beijing 112
Dallas 111
Princeton 104
Santa Clara 98
Los Angeles 90
Nanjing 66
Shanghai 60
The Dalles 55
Vienna 54
Altamura 53
Lawrence 47
Buffalo 45
Rome 40
Ho Chi Minh City 37
Moscow 36
Hanoi 35
São Paulo 34
Hefei 31
Lachine 31
Chicago 30
Council Bluffs 28
Helsinki 27
Dong Ket 26
Columbus 24
Guangzhou 24
Lissone 24
San Diego 23
Warsaw 23
Boston 21
London 21
Shenyang 20
San Jose 19
Munich 18
Nanchang 18
Orem 18
Ottawa 18
Brussels 17
Tokyo 17
Fremont 16
Phoenix 16
Tianjin 16
Toronto 16
Andover 15
Brooklyn 15
Pune 15
Changsha 14
Rio de Janeiro 14
Denver 13
Jiaxing 13
Johannesburg 13
Manchester 13
Atlanta 12
Boardman 12
Haiphong 12
Jakarta 12
Jinan 12
Mexico City 12
Montreal 12
Poplar 12
Seoul 12
Zhengzhou 12
Chennai 11
Bologna 10
Hebei 10
Nuremberg 10
Nürnberg 10
Stockholm 10
Brasília 9
Hangzhou 9
Kunming 9
Mountain View 9
Ningbo 9
Sacramento 9
San Francisco 9
Da Nang 8
Dhaka 8
Edmonton 8
Bergamo 7
Elk Grove Village 7
Guayaquil 7
Montréal 7
Taizhou 7
Tampa 7
Totale 7.682
Salva come PNG Salva come JPEG
Nome #
Impact of multidisciplinary team approach to liver tumors: 5-Years experience 468
Impact of multidisciplinary team approach to liver tumors in a tertiary center: 5-years experience 439
Clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology 399
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 336
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 289
Trattamento con Sofosbuvir e Ribavirina nei pazienti hcv-positivi listati per il trapianto di fegato: un analisi di costo-efficacia 282
Value-based outcome indicators in the management of hepatocellular carcinoma: Clinical test in a large multicenter study (VBMH study) 277
Health related quality of life in chronic liver diseases 277
Generation and performance of value-based outcome indicators in liver disease: The multicenter V.B.M.H. study 265
Accuracy of Transient Elastography in assessing fibrosis at diagnosis in naïve patients with Primary Biliary Cholangitis: a dual cut-off approach 264
Outcome indicators in liver cirrhosis: Application of value-based medicine in a large multicenter study (VBMH study) 261
Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort 260
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 256
P1169 : Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 255
Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 253
Outcome Indicators in Primary Sclerosing Cholangitis: Interim Analysis Of The Value-Based Medicine In Hepatology (VBMH) Study 251
P0811 : Sofosbuvir-based direct-acting antivirals treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 250
The impact of liver disease on the health-related quality of life 246
Value-based outcome indicators in liver cirrhosis: validation in a large multicenter study (VBMH study) 245
Direct-acting antivirals combination for elderly patients with chronic hepatitis C: A cost-effectiveness analysis 244
Characteristics of patients with Chronic Hepatitis C who have failed past treatment or who have never been treated: How much room left for Interferon? 243
Generation and Performance of Outcome Indicators in Liver Cirrhosis: The Value Based Medicine in Hepatology Study (V.B.M.H.) 236
Health Related Quality of Life in the Major Liver Conditions 236
Measurement of clinical outcomes and quality of life indicators as a new value-based approach to liver cirrhosis management 235
The Impact of Type of Liver Conditions on the Patients’ Health Related Quality of Life 227
A Comparison Between The Health-Related Quality Of Life Reported By The General Population And By Patients With Major Liver Diseases 227
A value-based approach to the management of patients with liver cirrhosis through the systematic measurement of clinical outcome and quality of life indicators 219
Impatto dei farmaci anti virali ad azione diretta sulla cura dei pazienti con epatite C: un approccio di value-based medicine 218
Sofosbuvir-based all-oral treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 216
Management of treatment-naïve chronic hepatitis C genotype 1 patients: A cost-effectiveness analysis of treatment options 214
Should new antiviral treatments be considered in elderly Chronic Hepatitis C patients? 212
PGI36 Relationship Between Clinical Severity and Health Related Quality of Life in Chronic Liver Diseases 211
Difference in health related quality of life of chronic liver diseases and general population 210
Value-based approach to hepatocellular carcinoma: outcome indicators tested in a large multicenter study (VBMH study) 208
PGI31 Health Care Indicators to Measure Quality of Care in Patients with Liver Diseases 206
Should Sofosbuvir-Based All-Oral Treatment Be Considered In Elderly Chronic Hepatitis C Patients? 205
The Cost-Effectiveness Of Sofosbuvir And Ribavirin Treatment In Hcv-Infected Patients Listed For Liver Transplantation 195
Clinical treatment of cholangiocarcinoma: an updated comprehensive review 193
Systematic review: economic evaluations of HCV screening in the direct-acting antivirals era 191
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 184
Management of chronic hepatitis C (Chc) genotype 1 treatment-naïve patients in an era of rising opportunities and costs: A cost-effectiveness analysis 183
Applicazione della value-based medicine nella valutazione della cura dei pazienti affetti da epatite. 179
Management of Chronic hepatitis C (CHC) Genotype 1 treatment-naive patients in an era of rising opportunities and costs - A cost-effectiveness analysis of treatment options 173
Cost-effectiveness of Sofosbuvir plus Ledipasvir Antiviral Treatment for Elderly Patients with Chronic Hepatitis C Genotype 1 172
Impact of metformin on the incidence of human cholangiocarcinoma in diabetic patients: A systematic review and meta-analysis 170
Is the risk of neoplastic recurrence increased after prescribing direct-acting antivirals for HCV patients whose HCC was previously cured? 165
Hepatitis C virus infection and diabetes: a complex bidirectional relationship 156
Functional liver imaging score (FLIS) can predict adverse events in HCC patients 154
Resistance analysis and treatment outcomes in hepatitis C virus genotype 3-infected patients within the Italian network VIRONET-C 150
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 147
Sofosbuvir and ribavirinin in HCV-infected patients listed for liver transplantation: A cost-effectiveness analysis 145
Cost-effectiveness of new direct-acting antivirals to prevent post-liver transplant recurrent hepatitis 143
Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy 113
Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens? 105
Totale 12.258
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.284
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.284
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021548 0 0 0 0 0 0 72 98 96 99 76 107
2021/2022771 70 87 87 85 32 57 13 53 37 65 49 136
2022/20231.344 144 446 121 111 82 170 31 82 97 9 38 13
2023/2024856 30 33 22 68 86 262 158 37 61 12 8 79
2024/20252.021 108 210 146 83 172 91 134 71 234 347 148 277
2025/20262.713 630 217 396 558 619 285 8 0 0 0 0 0
Totale 12.258